Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 CAD | 0.00% |
|
+3.08% | -14.10% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antigens,Quality Assessment Products and DxTM
91.8
%
| 19 | 100.0 % | 15 | 91.8 % | -20.49% |
Other (includes Kinlytic)
8.2
%
| 0 | 0.0 % | 1 | 8.2 % | +30,440.89% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
65.6
%
| 13 | 68.9 % | 11 | 65.6 % | -17.58% |
Europe
34.4
%
| 6 | 31.0 % | 6 | 34.4 % | -4.05% |
Other Foreign Countries
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | -73.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 07/03/12 |
James Currie
DFI | Director of Finance/CFO | - | 31/10/16 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Christopher Lobb
CMP | Compliance Officer | 65 | - |
Kenneth Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/94 |
Director/Board Member | 66 | 05/02/07 | |
Philip Casselli
SAM | Sales & Marketing | - | 31/12/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 01/10/90 |
Peter Blecher
BRD | Director/Board Member | - | 05/12/05 |
Cameron Groome
CEO | Chief Executive Officer | - | 07/03/12 |
Joseph Renner
BRD | Director/Board Member | - | 24/02/03 |
Martin Marino
CHM | Chairman | - | 16/02/09 |
Director/Board Member | 66 | 05/02/07 | |
Jennifer Stewart
BRD | Director/Board Member | - | 29/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 136,793,718 | 117,457,898 ( 85.86 %) | 0 | 85.86 % |
Company contact information
![address Microbix Biosystems Inc.(MBX)](https://cdn.zonebourse.com/static/address/1410740.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.10% | 33.42M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+36.05% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- MBX Stock
- Company Microbix Biosystems Inc.